In order to answer these questions, by using publicly available chromatin immunoprecipitation followed by sequencing (ChIP-seq) data, we predicted ERα-driven SEs in human breast cancer-derived MCF-7 and endometrial cancer-derived Ishikawa cell lines in which ERα is a key master regulator. The gene discussed is ESR1; the disease is endometrial cancer.